Dexcom Inc (DXCM): Depreciation & Amortization

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2010-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$251.80M
Year ended 2025-12-31
$264.10M
Trailing 12 months to 2026-06-30
+17.3%
3-year compound annual growth
+30.3%
5-year compound annual growth
+37.0%
10-year compound annual growth
2009-12-31: $2.37M2010-12-31: $2.40M2011-12-31: $3.80M2012-12-31: $6.60M2013-12-31: $7.00M2014-12-31: $8.40M2015-12-31: $10.80M2016-12-31: $15.00M2017-12-31: $16.10M2018-12-31: $29.10M2019-12-31: $48.70M2020-12-31: $67.10M2021-12-31: $102.00M2022-12-31: $155.90M2023-12-31: $186.00M2024-12-31: $217.70M2025-12-31: $251.80M$251.80M
2009-12-31 Depreciation & Amortization (USD) 2025-12-31
Period endedDepreciation & AmortizationChange YoYSource filing
2025-12-31$251.80M+15.7%2026-02-12, From 2025-01-01
2024-12-31$217.70M+17.0%2026-02-12, From 2024-01-01
2023-12-31$186.00M+19.3%2026-02-12, From 2023-01-01
2022-12-31$155.90M+52.8%2025-02-18, From 2022-01-01
2021-12-31$102.00M+52.0%2024-02-08, From 2021-01-01
2020-12-31$67.10M+37.8%2023-02-09, From 2020-01-01
2019-12-31$48.70M+67.4%2022-02-14, From 2019-01-01
2018-12-31$29.10M+80.7%2021-02-11, From 2018-01-01
2017-12-31$16.10M+7.3%2020-02-13, From 2017-01-01
2016-12-31$15.00M+38.9%2019-02-21, From 2016-01-01
2015-12-31$10.80M+28.6%2018-02-27, From 2015-01-01
2014-12-31$8.40M+20.0%2017-02-28, From 2014-01-01
2013-12-31$7.00M+6.1%2016-02-23, From 2013-01-01
2012-12-31$6.60M+73.7%2015-02-25, From 2012-01-01
2011-12-31$3.80M+58.3%2014-02-20, From 2011-01-01
2010-12-31$2.40Mn/c2013-02-21, From 2010-01-01
2009-12-31$2.37Mn/a2012-02-23, From 2009-01-01

Depreciation & Amortization at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedDepreciation & AmortizationChange YoY
Dexcom Inc (DXCM)2025-12-31$251.80M+15.7%
ResMed Inc (RMD)2026-06-30$201.34M+1.4%
MiniMed Group, Inc. (MMED)2026-04-24$156.00M+9.1%
West Pharmaceutical Services Inc (WST)2025-12-31$171.40M+10.3%
Globus Medical Inc (GMED)2025-12-31$276.84M+9.3%
Insulet Corp (PODD)2025-12-31$90.40M+11.9%
Solventum Corp (SOLV)2025-12-31$489.00M-11.9%
ICU Medical Inc (ICUI)2025-12-31$200.74M-8.6%
Teleflex Inc (TFX)2025-12-31$177.74M+10.0%

Compare DXCM, RMD, MMED, WST side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗